لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Lacombe K; Infectious Diseases Department, Inserm IPLESP, UMR-S1136, Hôpital Saint-Antoine, AP-HP, Sorbonne Université, Paris, France. Karine.lacombe2@aphp.fr.; Service des Maladies Infectieuses et Tropicales, Hôpital St Antoine, 184 rue du Fbg St Antoine, 75012, Paris, France. Karine.lacombe2@aphp.fr., Moh R; Unité Pédagogique de Dermatologie et Infectiologie, Université Félix Houphouet-Boigny, Abidjan, Côte d'Ivoire.; Programme PAC-CI, Site ANRS de Côte d'Ivoire, Abidjan, Côte d'Ivoire., Chazallon C; National Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Centre, University of Bordeaux, Bordeaux, France., Lemoine M; Hepatology Unit, Digestive Disease Division, Imperial College London, St Mary's Hospital, London, UK., Sylla B; IMEA, Hôpital Bichat - Claude Bernard, Paris, France., Fadiga F; Programme PAC-CI, Site ANRS de Côte d'Ivoire, Abidjan, Côte d'Ivoire., Le Carrou J; National Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Centre, University of Bordeaux, Bordeaux, France., Marcellin F; Inserm, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Aix Marseille Univ, Marseille, France., Kouanfack C; Hôpital de Jour, Hôpital Central, Yaoundé, Cameroon., Ciaffi L; TransVIHMI - IRD UMI233 - INSERM U1175, Université de Montpellier, Montpellier, France., Sartre MT; Clinique de la Cathédrale, Yaoundé, Cameroon., Sida MB; Faculté de Médecine et des Sciences Biomédicales, Université de Yaoundé 1, Yaoundé, Cameroon., Diallo A; Service de Pharmacovigilance, ANRS, Paris, France., Gozlan J; Department of Virology, INSERM, UMR_S 938, Centre de Recherche Saint-Antoine, Hôpital Saint-Antoine, AP-HP, Sorbonne Université, Paris, France., Seydi M; Service des Maladies Infectieuses et Tropicales, CHNU de Fann, Dakar, Senegal., Cissé V; Service des Maladies Infectieuses et Tropicales, Centre Régional de Recherche et de Formation, Site ANRS, CHNU de Fann, Dakar, Senegal., Danel C; IMEA, Hôpital Bichat - Claude Bernard, Paris, France., Girard PM; Infectious Diseases Department, Inserm IPLESP, UMR-S1136, Hôpital Saint-Antoine, AP-HP, Sorbonne Université, Paris, France., Toni TD; Service de Virologie, Centre de diagnostic et de recherche sur le SIDA, CHU Treichville, Abidjan, Côte d'Ivoire., Minga A; Centre National des Donneurs de Sang, Abidjan, Côte d'Ivoire., Boyer S; Hôpital de Jour, Hôpital Central, Yaoundé, Cameroon., Carrieri P; Hôpital de Jour, Hôpital Central, Yaoundé, Cameroon., Attia A; Service d'hépatologie, CHU de Yopougon, Abidjan, Côte d'Ivoire.

مؤلفون مشاركون: TAC ANRS12311 Study Group

المصدر: Scientific reports [Sci Rep] 2024 May 03; Vol. 14 (1), pp. 10244. Date of Electronic Publication: 2024 May 03.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Multicenter Study; Clinical Trial

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Antiviral Agents*/therapeutic use , Antiviral Agents*/adverse effects , Hepacivirus*/genetics , Hepacivirus*/drug effects , Sofosbuvir*/therapeutic use , Sofosbuvir*/adverse effects, Adult ; Female ; Humans ; Male ; Middle Aged ; Africa, Central ; Africa, Western ; Aminoisobutyric Acids ; Benzimidazoles/therapeutic use ; Benzimidazoles/adverse effects ; Benzopyrans ; Carbamates/therapeutic use ; Cyclopropanes/therapeutic use ; Cyclopropanes/adverse effects ; Drug Therapy, Combination ; Feasibility Studies ; Fluorenes/therapeutic use ; Fluorenes/adverse effects ; Genotype ; Hepatitis C/drug therapy ; Hepatitis C, Chronic/drug therapy ; Hepatitis C, Chronic/virology ; Heterocyclic Compounds, 4 or More Rings/therapeutic use ; Heterocyclic Compounds, 4 or More Rings/adverse effects ; Lactams, Macrocyclic ; Leucine/analogs & derivatives ; Proline/analogs & derivatives ; Proline/therapeutic use ; Quinoxalines ; Ribavirin/therapeutic use ; Ribavirin/adverse effects ; Sulfonamides/therapeutic use ; Sulfonamides/adverse effects ; Sustained Virologic Response ; Treatment Outcome

المؤلفون: Foupouapouognigni Y; Service de virologie, Centre Pasteur du Cameroun, P.O. Box 1274, Yaounde, Cameroon., Noah DN, Sartre MT, Njouom R

المصدر: Journal of clinical microbiology [J Clin Microbiol] 2011 Mar; Vol. 49 (3), pp. 1162-4. Date of Electronic Publication: 2011 Jan 05.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 7505564 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-660X (Electronic) Linking ISSN: 00951137 NLM ISO Abbreviation: J Clin Microbiol Subsets: MEDLINE

مواضيع طبية MeSH: Hepatitis D/*epidemiology , Hepatitis D/*virology , Hepatitis Delta Virus/*classification , Hepatitis Delta Virus/*isolation & purification, Adult ; Cameroon/epidemiology ; Cluster Analysis ; Female ; Genotype ; Hepatitis Antibodies/blood ; Hepatitis B/complications ; Hepatitis Delta Virus/genetics ; Humans ; Male ; Molecular Sequence Data ; Phylogeny ; Polymorphism, Genetic ; RNA, Viral/genetics ; Sequence Analysis, DNA ; Seroepidemiologic Studies

المؤلفون: Njouom R; Laboratoire de Virologie, Centre Pasteur du Cameroun, Yaounde, Cameroon. njouom@pasteur-yaounde.org, Sartre MT, Timba I, Nerrienet E, Tchendjou P, Pasquier C, Rousset D

المصدر: Journal of medical virology [J Med Virol] 2008 Dec; Vol. 80 (12), pp. 2079-85.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print Cited Medium: Internet ISSN: 1096-9071 (Electronic) Linking ISSN: 01466615 NLM ISO Abbreviation: J Med Virol Subsets: MEDLINE

مواضيع طبية MeSH: Antiviral Agents/*adverse effects , Antiviral Agents/*therapeutic use , Hepatitis C, Chronic/*drug therapy , Interferon-alpha/*adverse effects , Interferon-alpha/*therapeutic use , Polyethylene Glycols/*adverse effects , Polyethylene Glycols/*therapeutic use , Ribavirin/*adverse effects , Ribavirin/*therapeutic use, Adult ; Cameroon ; Drug Therapy, Combination ; Female ; Genotype ; Hepacivirus/classification ; Hepacivirus/isolation & purification ; Humans ; Interferon alpha-2 ; Male ; Middle Aged ; Recombinant Proteins ; Treatment Outcome ; Viral Load